33 episodes

This is the mp3 version. From episode 30 onward this is the same as the AAC version. Prior to that, the AAC version had chapter markings.

Talking About Glaucoma (mp3‪)‬ Robert M Schertzer, MD, MEd, FRCSC

    • Health & Fitness
    • 5.0 • 1 Rating

This is the mp3 version. From episode 30 onward this is the same as the AAC version. Prior to that, the AAC version had chapter markings.

    DeMORAES Gus 24--2C the origin story

    DeMORAES Gus 24--2C the origin story

    In this episode, I talk with Gus DeMoraes, a frequent guest of the pod. Gus is Associate Professor of Ophthalmology at Columbia University where he serves as Medical Director of Clinical Trials. When we originally sat down to record this way back in March 2019, he had just presented some of the work he had done in collaboration with Don Hood. This has now appeared on Humphrey perimeters as the 24-2C testing strategy and is becoming a new the standard of care. It is based on reports in recent years that glaucoma damage often occurs in the macular area but missed because the standard 24-2 testing strategy only tests in 6 degree increments. These early central glaucomatous defects are often hidden between the test points.

    • 13 min
    KIM Won Combined MIGS procedures

    KIM Won Combined MIGS procedures

    In this episode, I talk with Won Kim, a glaucoma colleague based on Walter Reed in Bethesda, Maryland, about how he has been combining multiple minimally invasive glaucoma procedures in patients who have failed traditional glaucoma surgery. I'm Rob Schertzer, a Vancouver, Canada based glaucoma specialist, podcaster and HealthIT expert, and we're...talking about glaucoma.

    • 13 min
    LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (mp3)

    LEWIS Rick Rho Kinase Inhibitors: a new class of drugs (mp3)

    The goal of the late Dave Epstein was to find a drug that treats the cause of glaucoma by improving trabecular meshwork outflow. After many years of trying, Aerie Pharmaceuticals was formed and refined a Rho Kinase inhibitor called Netarsudil. In April 2018 this came to market as Rhopressa and March 2019, combined with latanoprost, as Roclatan. Today I’m talking with Rick Lewis, a glaucoma colleague based in Sacramento and Chief Medical Officer for Aerie Pharmaceuticals.

    • 12 min
    Talking About Glaucoma #30 - 5Nov2018 JOHNSTONE Murray Pulsatile Flow (mp3)

    Talking About Glaucoma #30 - 5Nov2018 JOHNSTONE Murray Pulsatile Flow (mp3)

    In this episode, I talk with Murray Johnstone from Seattle about pulsatile flow through the Trabecular Meshwork and collector channels. We discuss the imaging improvements over the years that have made this possible including the latest phase-based OCT scans that result in nanometre resolution instead of the micrometre resolution of spectral domain scans that most of us are using in clinical practice.

    • 35 min
    Talking About Glaucoma #29 - 29Jan2018 FELLMAN Fluid Wave (mp3)

    Talking About Glaucoma #29 - 29Jan2018 FELLMAN Fluid Wave (mp3)

    I sat down with Ron Fellman at a recent American Glaucoma Society meeting to discuss the use of the fluid wave in assessing the aqueous humour outflow pathway and its clinical application.

    • 19 min
    TAG Episode 28 - 18July2017: JOHNSON pet peeves in perimetry (mp3)

    TAG Episode 28 - 18July2017: JOHNSON pet peeves in perimetry (mp3)

    I sat down with Chris Johsnon at a recent American Glaucoma Society meeting to discuss some of my pet peeves about visual field testing and what lies on the horizon. Chris is Professor of Ophthalmology and Visual Sciences at the University of Iowa and a world renown Perimetry expert.

    • 16 min

Customer Reviews

5.0 out of 5
1 Rating

1 Rating

Top Podcasts In Health & Fitness

Listeners Also Subscribed To